Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SELLAS Life Sciences (SLS) FCF Margin (2020 - 2022)

SELLAS Life Sciences (SLS) has disclosed FCF Margin for 3 consecutive years, with 715.0% as the latest value for Q1 2022.

  • On a quarterly basis, FCF Margin fell 53484.0% to 715.0% in Q1 2022 year-over-year; TTM through Dec 2022 was 2380.9%, a 203852.0% decrease, with the full-year FY2022 number at 2380.9%, down 203852.0% from a year prior.
  • FCF Margin was 715.0% for Q1 2022 at SELLAS Life Sciences, down from 257.79% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 180.21% in Q4 2020 to a low of 715.0% in Q1 2022.
  • A 3-year average of 243.18% and a median of 218.97% in 2021 define the central range for FCF Margin.
  • Biggest YoY gain for FCF Margin was -53484bps in 2022; the steepest drop was -53484bps in 2022.
  • SELLAS Life Sciences' FCF Margin stood at 180.21% in 2020, then plummeted by -243bps to 257.79% in 2021, then crashed by -177bps to 715.0% in 2022.
  • Per Business Quant, the three most recent readings for SLS's FCF Margin are 715.0% (Q1 2022), 257.79% (Q2 2021), and 180.16% (Q1 2021).